Novel Sunitinib Strategy in Metastatic Renal Cell Carcinoma on Hemodialysis: Intermittent Dose of Sunitinib after Hemodialysis

The proper dose and schedule of sunitinib have yet to be established for patients with metastatic renal cell carcinoma (RCC) on hemodialysis. We reviewed two patients with metastatic RCC on hemodialysis who had been treated with sunitinib in Yonsei Cancer Center, Yonsei University College of Medicin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Yoon, Sang Hyun, Kim, Ki Hyang, Choi, Junjeong, Kim, Gun Min, Kim, Joo Hoon, Kim, Hyo Song, Park, Young Nyun, Rha, Sun Young
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Korean Cancer Association 2010
Gaiak:
Case Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2953783/
https://ncbi.nlm.nih.gov/pubmed/20948925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2010.42.3.180
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak